CN1935272A
|
|
Method for preparing recombinant neuro surrogate
|
CN1899227A
|
|
Expanding type spongy bone hollow screw
|
CN1821404A
|
|
Rabbit anti-human CIDE-3 protein poly clonal antibody
|
CN1858253A
|
|
Screening method for human gastric cancer drug-resistant cell specific combination and drug-resistant reverse short peptide and sequence
|
CN1748634A
|
|
Hard membrane outer pressure detecting mechanism method and device
|
CN1899612A
|
|
Therapeutical peptide hepatitis C vaccine and its preparing method
|
CN1899611A
|
|
Therapeutical polypeptide hepatitis B vaccine and its preparing method
|
CN1899613A
|
|
Therapeutic polypeptide hepatitis B vaccine and its preparing method and using method
|
CN1714746A
|
|
Non-contact magnetic inductive encephaledema monitoring method
|
CN1810957A
|
|
Immortal human bone marrow matrix stem cell line and its establishing process
|
CN1641036A
|
|
Humandrg2 recombinant adenovirus expresion vector configuration and use of anti-tumour recombinant adenovirus
|
CN1782075A
|
|
Design constructing method of gene engineering recombined dyad bone shape protein
|
CN1616109A
|
|
Method for MG 7-Ag analogue epitope to construct stomack cancer specific poly epitope gene vaccine
|
CN1559343A
|
|
Electrical impedance scanning-projection imaging method for early diagnosis of mammary gland mass
|
CN1528452A
|
|
Method for preparing broad spectrum genetically engineered nano vaccine for malignant tumour
|
CN1535985A
|
|
Genetically-engineered single chain antibody scFv 25 for resisting liver cancen
|
CN1405185A
|
|
Tumour vascular-targeting and novel recombinant human tumour necrosis factor fusion protein and its preparation
|
CN1357621A
|
|
Establishing method of active cell strain for quantitative determination of bone morphogenetic protein (BMP)
|
CN1348005A
|
|
Prepn and use of reconstituted target cysteine asparagusic enzyme gene
|
CN1337211A
|
|
Operation positioning method from sphernoidal sinus to saddle ragion and simple positioning instrument
|